±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 126  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß sunmaocai µÄ 5 ¸ö½ð±Ò

sunmaocai

Í­³æ (СÓÐÃûÆø)

[½»Á÷] ÇóÎÄÏ×

°ûà×à¤ÍѰ±Ã¸APOBEC3G¿ÉÄÜͨ¹ýG¡úAÍ»±äÒÖÖÆÒÒÐ͸ÎÑײ¡¶¾µÄ¸´ÖÆ

[ Last edited by 350784478 on 2009-7-14 at 10:26 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xieli

ľ³æ (ÕýʽдÊÖ)

¸çÃÇ£¬Ö»ÓÐÕâЩ£¬²»ºÃÒâ˼ÁË

¡ï ¡ï ¡ï
reasonspare(½ð±Ò+3,VIP+0):лл·ÖÏí£¬»¶Ó­³£À´
Õª¡¡Òª:Ä¿µÄ Ñо¿°ûà×à¤ÍѰ±Ã¸APOBEC3G£¨A3G£©¶ÔHBV¸´ÖƵÄÓ°Ïì¼°×÷ÓûúÖÆ¡£·½·¨ ÀûÓÃÖ¬ÖÊÌå½éµ¼A3GºÍHBVµÄÕæºË±í´ïÖÊÁ£Ë²Ê±¹²×ªÈ¾È˸ΰ©Ï¸°ûÖêHepG2£¬ÒÔ¿ÕÔØÌåpcDNA3£®1ÓëHBVÕæºË±í´ïÖÊÁ£¹²×ªÈ¾Îª¶ÔÕÕ£¬Í¬Ê±×ªÈ¾º¬ÔöÇ¿ÐÍÂÌɫӫ¹âµ°°×£¨EGFP£©»ùÒòµÄÖÊÁ£ÔØÌåÒÔÅж¨×ªÈ¾Ð§ÂÊ¡£¹²×ªÈ¾Á½ÌìºóÓÃÓ«¹â¶¨Á¿PCR·½·¨¶¨Á¿Ï¸°ûÄں˿ÇÌ壨cofe£©Ïà¹ØHBV DNAˮƽ£¬ÓÃWestern blot¼ì²âϸ°ûÄÚA3GºÍHBcAgµÄ±í´ï£¬²¢¶Ôϸ°ûÄÚcofeÏà¹ØHBVDNAX»ùÒò½øÐÐPCRÀ©Ôö¡¢T£®A¿Ë¡ºÍ²âÐò£¬·ÖÎöX»ùÒòÖеļî»ùÍ»±ä¡£½á¹û ¾­EGFPÅж¨µÄתȾЧÂÊÆ½¾ùΪ29£¥¡£¹²×ªÈ¾0£®5PgA3GºÍ0£®5¦Ìg HBVµÄHepG2ϸ°ûÄÚcoreÏà¹ØHBVDNAÁ¿Æ½¾ùϽµÎª¶ÔÕÕµÄ8£®9£¥£¬¹²×ªÈ¾2¦ÌgA3GºÍ0£®5¦ÌgHBVµÄƽ¾ùϽµÎª¶ÔÕÕµÄ0£®6£¥¡£¹²×ªÈ¾A3GºÍHBV±í´ïÖÊÁ£ºó£¬HepG2ϸ°ûÄÚHBVµÄX»ùÒòÖз¢ÉúG¡úAÍ»±äµÄÊýÄ¿Ã÷ÏÔÔö¶à£¬33¸ö¿Ë¡ÖÐÓÐ9¸ö¿Ë¡¼ì²âµ½ÁË16-37¸öG¡úAÍ»±ä£¬Í»±ä×ÜÊý´ï254¸ö£¬¶ø¶ÔÕÕµÄ33¸ö¿Ë¡ÖнöÓÐ2¸ö¿Ë¡¸÷¼ì²âµ½2¸öG¡úAÍ»±ä¡£½øÒ»²½µÄ·ÖÎö·¢ÏÖ£¬¹²×ªÈ¾A3Gºó·¢ÉúµÄG¡úAÍ»±ä´ó¶à¼¯ÖÐÓÚ¼¸¸öÈȵãÇøÓò£¬Í»±ä°Ðµã³£ÔÚGG¶þºËÜÕËáÖеĵÚÒ»¸öGÉÏ¡£½áÂÛ °ûà×à¤ÍѰ±Ã¸APOBEC3G¿ÉÄÜͨ¹ýÓÕµ¼HBVDNAµÄX»ùÒò·¢ÉúG¡úA³¬Í»±ä£¬ÒÖÖÆHBVÔÚÈ˸ΰ©Ï¸°ûHepG2Öеĸ´ÖÆ¡£[ÖøÕßÎÄÕª]

¹Ø¼ü´Ê:APOBEC3G °ûà×à¤ÍѰ±Ã¸ ÒÒÐ͸ÎÑײ¡¶¾ Í»±ä
·ÖÀàºÅ:¡¡R512.91[»ú±ê]ÎÄÏ×±êʶÂ룺ÎÄÕ±àºÅ£ºÀ¸Ä¿ÐÅÏ¢£º²¡¶¾Ñ§
Ïà¹ØÎÄÏ×:Ö÷ÌâÏà¹Ø È«ÎÄ¿ìÕÕ¡¡¡¡¡¡

Cytidine deaminase APOBEC3G my suppress HBV replication through G to A mutation of HBV X gene regionZHANG Wei, ZHANG Xu-zhao, FANG Yong-ming, HE Zhi-wen, YING Song-cheng, XU Rong-zhen, YU Xiao-fang. Cancer Institute, Second Affdiated Hospital, School of Medicine, Zhejiang University, Haagzhou 310009, ChinaAbstract:Objective To investigate whether APOBEC3G£¨A3G£© can mediate cytosine deamination of HBV DNA and suppress HBV replication. Methods An expressing vector encoding A3G or a control vector pcD- NA3.1 was co-transfected with a HBV-producing plasmid into human hepatoma cell line HepG2. Meanwhile, an expressing vector encoding green fluorescence protein was also transfected into HepG2 in order to determine the transfection efficiency. Cells were harvested two days after transfection, and introcellular core-associated HBV DNA was extracted. Purified HBV DNA was quantified by real-tlme PCR. Wostem blot analysis was performed on cytoplasmic extracts from these cells, with the antibodies against HBV core protein and HA. X gene region of coreassociated HBV DNA was amplified, and the PCR products were cloned into pGEM-T Easy and individual recombinant clones were sequenced. GeneDoc software was used to analyze the sequences. Results The transfection effi- ciency was about 29%. Compared to the empty vector control, 0.5 p-g A3G reduced the formation of intracellular core-associated HBV DNA to 8.9%, and 2¦Ìg A3G to 0.6%. Low level of G to A mutation in the X gene region of HBV DNA was detected from samples collected from HepG2 cells transfected with a control vector. A3G increased G to A mutations in the X region of HBV DNA. About 2 of 33 recombinant bacterial clones from control HepG2 cells mmsfected with vector contained only two G to A mutations. On the other hand, 9 of 33 clones conrained sixteen or more G to A mutations in the presence of A3G, and the total number of G to A mutations was up to 254. Further analysis indicated that the G to A mutation showed a preference for the first G of a dinucleotide sequence of GG. Conclusion Cytidine deaminase A3G may suppress HBV replication in HepG2 cells through G to A hypermutation of the X region of HBV DNA.[ÖøÕßÎÄÕª]

Key words:APOBEC3G; Cytidine deaminase; Hepatitis B virus; Mutation
¿àÈ¥¸ÊÀ´
2Â¥2008-08-14 10:40:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ sunmaocai µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 299Çóµ÷¼Á +9 15188958825 2026-03-25 9/450 2026-03-29 14:16 by wxiongid
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á +14 µ¾ÆÞС±à 2026-03-26 14/700 2026-03-29 14:09 by wxiongid
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©µ÷¼Á +5 Feisty¡£ 2026-03-28 9/450 2026-03-29 12:02 by longlotian
[¿¼ÑÐ] 317·Ö Ò»Ö¾Ô¸ÄÏÀí¹¤²ÄÁϹ¤³Ì ±¾¿Æºþ¹¤´ó Çóµ÷¼Á +9 ÓóÄàСÁåîõ 2026-03-28 9/450 2026-03-29 11:46 by longlotian
[¿¼ÑÐ] 356Çóµ÷¼Á +4 gysy?s?a 2026-03-28 4/200 2026-03-29 10:32 by ÌÆãå¶ù
[¿¼ÑÐ] 0856²ÄÁÏ»¯¹¤µ÷¼Á ×Ü·Ö330 +14 zhubinhao 2026-03-27 14/700 2026-03-29 10:01 by Sjndkwm
[¿¼ÑÐ] һ־Ը̫ԭÀí¹¤°²È«¹¤³Ì300·Ö£¬Çóµ÷¼Á +5 0857Çóµ÷¼Á. 2026-03-24 6/300 2026-03-28 22:04 by zhq0425
[¿¼ÑÐ] Ò»Ö¾Ô¸±±»¯085600²ÄÁÏר˶275|ÓÐÎÄÕÂרÀû£üÇóµ÷¼Á +7 Micky11223 2026-03-25 7/350 2026-03-28 18:34 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 394Çóµ÷¼Á +3 ºÃʶàÄ¥¾²ºò¼ÑÒ 2026-03-26 5/250 2026-03-28 14:24 by ÌÆãå¶ù
[¿¼ÑÐ] 086502»¯Ñ§¹¤³Ì342Çóµ÷¼Á +6 °¢Ò̸´¹Å²»¹ý 2026-03-27 6/300 2026-03-28 07:06 by wangy0907
[¿¼ÑÐ] 265Çóµ÷¼Á +8 Сľ³æ085600 2026-03-27 8/400 2026-03-27 22:16 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 287Çóµ÷¼Á +10 land xuxu 2026-03-26 10/500 2026-03-27 15:33 by ÅÁ¶ûÂíÀ­ÌØ
[¿¼ÑÐ] °²»Õ´óѧר˶ÉúÎïÓëҽҩרҵ(086000)324·Ö£¬Ó¢ÓïÒѹýËÄÁù¼¶£¬Áù¼¶521£¬Çóµ÷¼Á +4 ÃÀζ¿ÉÀÖ¼¦³á 2026-03-26 4/200 2026-03-27 15:27 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 322Çóµ÷¼Á +4 ÎÒÕæµÄºÜÏëѧϰ 2026-03-23 4/200 2026-03-27 13:51 by ÑîÑîÑî×Ï
[¿¼ÑÐ] 314Çóµ÷¼Á +3 ÏªÔÆçæ 2026-03-26 3/150 2026-03-27 11:20 by sanrepian
[ÂÛÎÄͶ¸å] Journal of Mechanical Science and Technology +3 Russ_ss 2026-03-25 5/250 2026-03-27 10:49 by ½С¹û»­´ó±ý
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ¹¤´ó 081700 276Çóµ÷¼Á +4 µØÇòÈÆ×ÅÌ«Ñôת 2026-03-23 4/200 2026-03-26 14:27 by zzll406
[¿¼ÑÐ] 309Çóµ÷¼Á +4 gajsj 2026-03-25 5/250 2026-03-26 00:27 by Dyhoer
[¿¼ÑÐ] 332Çóµ÷¼Á +6 032500 2026-03-25 6/300 2026-03-25 22:45 by 418490947
[¿¼ÑÐ] 341Çóµ÷¼Á(Ò»Ö¾Ô¸ºþÄÏ´óѧ070300) +5 ·¬ÇÑÍ·--- 2026-03-22 6/300 2026-03-23 23:45 by Txy@872106
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û